Preferred Name |
Meloxicam |
|
Synonyms |
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide MELOXICAM Meloxicam Mobec Mobic Mobicox Movalis Movatec |
|
Definitions |
An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61439 |
|
CAS_Registry |
71125-38-7 |
|
Chemical_Formula |
C14H13N3O4S2 |
|
code |
C61439 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 |
|
Contributing_Source |
CTRP FDA |
|
DEFINITION |
An oxicam derivative and a non-steroidal anti-inflammatory drug (NSAID) with anti-inflammatory, antipyretic and analgesic activities. Unlike traditional nonselective NSAIDs, meloxicam preferentially inhibits the activity of cyclo-oxygenase II (COX-II), resulting in a decreased conversion of arachidonic acid into prostaglandin precursors. The resulting decrease in prostaglandin synthesis is responsible for the therapeutic effects of meloxicam. |
|
Display_Name |
Meloxicam |
|
FDA_UNII_Code |
VG2QF83CGL |
|
FULL_SYN |
4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide MELOXICAM Meloxicam Mobec Mobic Mobicox Movalis Movatec |
|
Has_Target | ||
label |
Meloxicam |
|
Legacy Concept Name |
Meloxicam |
|
NCI_Drug_Dictionary_ID |
472195 |
|
PDQ_Closed_Trial_Search_ID |
472195 |
|
PDQ_Open_Trial_Search_ID |
472195 |
|
Preferred_Name |
Meloxicam |
|
prefixIRI |
Thesaurus:C61439 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0083381 |
|
subClassOf |